Circassia Pharmaceuticals (GB:NIOX) has released an update.
Circassia Pharmaceuticals, trading as NIOX Group plc, has updated its total voting rights following the exercise of options by employees, resulting in an issued share capital of 424,127,241 Ordinary Shares. Shareholders can use this new share figure as a reference for disclosing their interest in the company, in line with FCA’s rules. No shares are currently held in treasury, ensuring full transparency for investors.
For further insights into GB:NIOX stock, check out TipRanks’ Stock Analysis page.
